Prevention Of Atheromatous Heart Disease
By O.P. Agarwal, M.D., F.I.C.A.
Angiology, Vol 36, Number 8, August 1985
Presented at the 31st Annual Meeting, American College of Angiology and
26th Annual Meeting,International College of Angiology, November 5, 1984.
AbstractFive thousand patients of atheromatous heart disease, presented as angina
pectoris, were studied over a period of five years. After adding the “Husk of Isabgol” and “Aloe vera” (an
indigenous plant known as ghee-guar-ka-paththa) to the diet, a marked reduction in total serum cholesterol, serum
triglycerides, fasting and post parandial blood sugar level in diabetic patients, total lipids and also increase in
HDL were noted. Simultaneously the clinical profile of these patients showed reduction in the frequency of anginal
attacks and gradually, the drugs, like verapamil, nifedipine, beta-blockers and nitrates, were tapered. The
patients, most benefitted, were diabetics (without adding any antidiabetic drug). The exact mechanism of the action
of the above two substances is not known, but it appears, that probably they act by their high fibre contents. Both
these substances need further evaluation. The most interesting aspect of the study was that no untoward side effect
was noted and all the five thousand patients are surviving till date.
IntroductionIncidence of atheromatous heart disease is
increasing day by day. The factors commonly responsible for atherosclerotic heart disease are
diabetes mellitus, hypertension, smoking, family tendency in the form of hyperlipidemias, gout,
excessive intake of saturated fatty acids, obesity, lack of exercise, etc.
For the first time, an Indian plant known as Aloe vera belonging to
the Liliacee family along with the Husk of Isabgol, was tried on five thousand patients who had
proved ischaemic heart disease due to atherosclerosis and the above two herbal medicines proved
to be very effective when mixed with wheat flour paste before preparing the bread. This plant;
Aloe vera, is used in Indian medicine as a tonic, purgative, aphrodisiac, antihelminthic, in
various opthalmological disorders, enlargement of spleen, various forms of hepatitis, vomiting,
fever due to bronchitis, erysipelas, skin disorders, asthma, leprosy, jaundice, strangury, as a
carminative, various musculoskeletal disorders, menstrual suppression and various other
nonspecific disorders.
Table I
Sex
|
Total
Patients
|
Age
Group
|
No. Of
Patients
|
Diabetic
Patients
|
Family
History Of
Diabetics
|
Total
Hyper- tensives
|
Mild
|
Moderate
|
M
|
3489
|
35-40
|
869
|
612
|
408
|
115
|
65
|
50
|
M
|
|
41-50
|
1050
|
823
|
639
|
325
|
201
|
124
|
M
|
|
51-65
|
1570
|
989
|
805
|
467
|
301
|
166
|
Non- Diabetic Patients
|
|
|
1065
|
|
|
589
|
381
|
208
|
F
|
1511
|
35-40
|
231
|
85
|
60
|
25
|
15
|
10
|
F
|
|
41-50
|
589
|
207
|
189
|
67
|
49
|
18
|
F
|
|
51-65
|
691
|
451
|
371
|
210
|
108
|
102
|
Non- Diabetic Patients
|
|
|
768
|
|
|
353
|
240
|
113
|
|
5000
|
|
5000
|
3167
|
2472
|
2151
|
1360
|
791
|
Table II
Age Group
|
No. Of
Patients
|
Anterior Wall
Ischaemia
|
Inferior Wall
Ischaemia
|
Male Diabetics |
|
|
|
35-41 |
612
|
398
|
214
|
41-50 |
823
|
526
|
297
|
51-65 |
989
|
605
|
384
|
Male
Non-Diabetics |
1065
|
424
|
641
|
Female Diabetics |
|
|
|
35-40 |
85
|
31
|
54
|
41-50 |
207
|
96
|
111
|
51-65 |
451
|
302
|
149
|
Female
Non-Diabetics |
768
|
438
|
330
|
|
5000
|
2820
|
2180
|
|
Table III
Fasting Blood Sugar (Normal 60-110 Mgm%)
Sex
|
Age
Group
|
No. Of
Patients
|
111-125
Mgm%
|
126-150
Mgm%
|
Males
|
35-40
|
612
|
398
|
214
|
|
41-50
|
823
|
564
|
259
|
|
51-65
|
989
|
598
|
391
|
Females
|
35-40
|
85
|
48
|
37
|
|
41-50
|
207
|
140
|
67
|
|
51-65
|
451
|
299
|
152
|
|
|
3167
|
2047
|
1120
|
Post Parendial Blood Sugar (Normal 100-160 Mgm%)
Sex
|
Age
Group
|
No. Of
Patients
|
161-250
Mgm%
|
251-400
Mgm%
|
Males
|
35-40
|
612
|
405
|
207
|
|
41-50
|
823
|
530
|
293
|
|
51-65
|
989
|
611
|
378
|
Females
|
35-40
|
85
|
42
|
43
|
|
41-50
|
207
|
131
|
76
|
|
51-65
|
451
|
305
|
146
|
|
|
3167
|
2024
|
1143
|
Table IV
Total Serum Cholesterol (Normal 125-285 Mgm%)
Sex
|
Age
Group
|
No. Of
Patients
|
286-350
Mgm%
|
351-425
Mgm%
|
426-500
Mgm%
|
Males |
35-40
|
612
|
309
|
198
|
105
|
Diabetics |
41-50
|
823
|
429
|
256
|
138
|
|
51-65
|
989
|
547
|
232
|
210
|
Non-Diabetic
Males |
|
1065
|
219
|
657
|
189
|
Females |
35-40
|
85
|
25
|
40
|
20
|
Diabetics |
41-50
|
207
|
67
|
108
|
32
|
|
51-65
|
451
|
112
|
298
|
95
|
Non-Diabetic
Females |
|
768
|
204
|
469
|
95
|
|
|
5000
|
1912
|
2258
|
830
|
Table V
Serum Triglycerides (Normal Level 40-150 Mgm%)
Age Group
|
No. Of
Patients
|
151-170
|
171-200
|
201-250
|
Male Diabetics |
|
|
|
|
35-40 |
612
|
305
|
203
|
104
|
41-50 |
823
|
415
|
301
|
107
|
51-65 |
989
|
509
|
249
|
231
|
Male
Non-Diabetics |
1065
|
208
|
701
|
156
|
Female Diabetics |
|
|
|
|
35-40 |
85
|
20
|
44
|
21
|
41-50 |
207
|
61
|
112
|
34
|
51-65 |
451
|
108
|
304
|
39
|
Female
Non-Diabetics |
768
|
198
|
502
|
68
|
|
5000
|
1824
|
2416
|
760
|
Table VI
Total Lipids (Normal Value 450-850 Mgm%)
Age Group
|
No. Of
Patients
|
851-1000
|
1001-1200
|
1201-1350
|
Male Diabetics |
|
|
|
|
35-40 |
612
|
291
|
180
|
141
|
41-50 |
823
|
402
|
281
|
140
|
51-65 |
989
|
517
|
241
|
231
|
Male
Non-Diabetics |
1065
|
205
|
670
|
190
|
Female Diabetics |
|
|
|
|
35-40 |
85
|
22
|
42
|
21
|
41-50 |
207
|
61
|
111
|
35
|
51-65 |
451
|
104
|
313
|
40
|
Female
Non-Diabetics |
768
|
198
|
480
|
90
|
|
5000
|
1800
|
3118
|
882
|
Table VII
HDL Cholesterol (Normal Level 25 Mgm% to 75 Mgm%)
Age Group
|
No. Of
Patients
|
20-25
|
26-30
|
31-35
|
Male Diabetics |
|
|
|
|
35-40 |
612
|
401
|
176
|
35
|
41-50 |
823
|
509
|
289
|
25
|
51-65 |
989
|
610
|
260
|
119
|
Male
Non-Diabetics |
1065
|
304
|
677
|
84
|
Female Diabetics |
|
|
|
|
35-40 |
85
|
15
|
50
|
20
|
41-50 |
207
|
101
|
98
|
8
|
51-65 |
451
|
156
|
258
|
37
|
Female
Non-Diabetics |
768
|
212
|
470
|
86
|
|
5000
|
2308
|
2278
|
414
|
The plant has never been tried in the prevention of atherosclerotic
heart disease. The other substance, Husk of Isabgol, in Indian medicine is mainly used to
increase the bulk of faeces in constipation. This study is mainly based on its
antiatherosclerotic properties.
Materials And MethodsFive thousand patients were selected for
the study ranging from 35-65 years of age. (Table I) All patients had clear cut evidence
of ischaemic heart disease in the form of unequivocal ECG changes apart from effort angina.
(Table II) All patients were subjected to serum chemistry and were screened for fasting
blood sugar, post parandial blood sugar (Table III), total serum cholesterol (Table
IV), serum triglycerides (Table V), total lipids (Table VI), HDL cholesterol
(Table VII), BUN & other investigations were normal.
Out of 5'000 patients, 3167 were diabetics; 2572 patients had a
history of smoking 10 to 15 cigarettes per day, for about five years; 2151 patients had
evidence of hypertension which was not renal in origin. Out of these 2151 hypertensives, 1360
had mild hypertension and 791 patients had moderate hypertension. The patients, who had
unstable angina, past history of myocardial infarction, severe hypertension, severe diabetics
& patients on insulin therapy, history of left ventricular failure, gout, were not included
in the study. Out of 1065 male non-diabetics, 912 had family history of hyperlipidemia and out
of 768 female non-diabetic patients, 454 patients were having family history of hyperlipidemia.
All 5000 patients were instructed not to consume alcohol in any form during the study. Smoking
was also not allowed during study period.
All 5'000 patients were instructed to take 100 gms of fresh flesh
gelatin of the plant Aloe vera and 20 gms of Husk of Isabgol mixed with wheat flour to prepare
the bread. These breads were consumed at lunch and dinner. Apart from this, the strict dietary
schedule and the drugs, which these patients were already taking, in the form of beta blockers,
verapamil, nifedipine, isosorbide dinitrate, sulphonylureas, digoxin and diuretics and
B-complex, were asked to continue and report weekly. All these patients were assessed
clinically and biochemically.
Table VIII
Tread Mill Test Reading After One Year of Treatment
Age Group
|
No. Of
Patients
|
Anterior
Wall
Ischaemia
|
No Evidence
Of
Ischaemia
|
Inferior
Wall
Ischaemia
|
No
Ischaemia
|
Male Diabetics |
|
|
|
|
|
35-40 |
612
|
398
|
396
|
214
|
202
|
41-50 |
823
|
526
|
500
|
297
|
276
|
51-65 |
989
|
605
|
600
|
384
|
341
|
Male
Non-Diabetics |
1065
|
424
|
399
|
641
|
582
|
Female Diabetics |
|
|
|
|
|
35-40 |
85
|
31
|
29
|
54
|
52
|
41-50 |
207
|
96
|
93
|
111
|
107
|
51-65 |
451
|
302
|
259
|
149
|
133
|
Female
Non-Diabetics |
768
|
438
|
388
|
330
|
295
|
|
5000
|
2820
|
2664
|
2180
|
1988
|
Table IX
Serum Cholesterol Levels Returned After Three Months (160-240 Mgm%)
Age Group
|
No. Of
Patients
|
290-350
|
Normal
|
351-425
|
Normal
|
426-500
|
Normal
|
Male Diabetics |
|
|
|
|
|
|
|
35-40 |
612
|
309
|
306
|
198
|
192
|
105
|
100
|
41-50 |
823
|
429
|
408
|
256
|
238
|
138
|
130
|
51-65 |
989
|
547
|
504
|
232
|
231
|
210
|
206
|
Male
Non-Diabetics |
1065
|
219
|
200
|
657
|
599
|
189
|
182
|
Female Diabetics |
|
|
|
|
|
|
|
35-40 |
85
|
25
|
23
|
40
|
39
|
20
|
19
|
41-50 |
207
|
67
|
65
|
108
|
106
|
32
|
29
|
51-65 |
451
|
112
|
101
|
298
|
251
|
41
|
40
|
Female
Non-Diabetics |
768
|
204
|
162
|
469
|
431
|
95
|
90
|
|
5000
|
1912
|
1769
|
2258
|
2087
|
830
|
796
|
Table X
Serum Trigylcerides Returned After Three Months (50-90 Mgm%)
Age Group
|
No. Of
Patients
|
151-170
|
Normal
|
171-200
|
Normal
|
201-250
|
Normal
|
Male Diabetics |
|
|
|
|
|
|
|
35-40 |
612
|
305
|
300
|
203
|
200
|
104
|
98
|
41-50 |
823
|
415
|
399
|
301
|
300
|
107
|
77
|
51-65 |
989
|
509
|
489
|
249
|
229
|
231
|
223
|
Male
Non-Diabetics |
1065
|
208
|
158
|
701
|
680
|
156
|
143
|
Female Diabetics |
|
|
|
|
|
|
|
35-40 |
85
|
20
|
18
|
44
|
43
|
21
|
20
|
41-50 |
207
|
61
|
60
|
112
|
110
|
34
|
30
|
51-65 |
451
|
108
|
69
|
304
|
288
|
39
|
35
|
Female
Non-Diabetics |
768
|
198
|
140
|
502
|
485
|
66
|
58
|
|
5000
|
1824
|
1633
|
2416
|
2335
|
760
|
684
|
Table XI
Total Lipids After Three Months of Treatment
Age Group
|
No. Of
Patients
|
851-1000
|
Normal
|
1001-1200
|
Normal
|
1200-1350
|
Normal
|
Male Diabetics |
|
|
|
|
|
|
|
35-40 |
612
|
291
|
282
|
180
|
176
|
141
|
140
|
41-50 |
823
|
402
|
370
|
281
|
268
|
140
|
138
|
51-65 |
989
|
517
|
499
|
241
|
213
|
231
|
229
|
Male
Non-Diabetics |
1065
|
205
|
155
|
670
|
650
|
190
|
176
|
Female Diabetics |
|
|
|
|
|
|
|
35-40 |
85
|
22
|
21
|
42
|
41
|
21
|
19
|
41-50 |
207
|
61
|
60
|
111
|
109
|
35
|
31
|
51-65 |
451
|
104
|
84
|
313
|
282
|
34
|
25
|
Female
Non-Diabetics |
768
|
198
|
168
|
480
|
430
|
90
|
85
|
|
5000
|
1800
|
1639
|
2318
|
2170
|
882
|
943
|
Table XII
HDL Cholesterol (Normal 50-75 Mgm) After Three Months
Age Group
|
No. Of
Patients
|
20-25
|
Normal
|
26-30
|
Normal
|
31-35
|
Normal
|
Male Diabetics |
|
|
|
|
|
|
|
35-40 |
612
|
401
|
390
|
176
|
174
|
35
|
34
|
41-50 |
823
|
509
|
478
|
289
|
279
|
25
|
19
|
51-65 |
989
|
610
|
580
|
260
|
250
|
119
|
111
|
Male
Non-Diabetics |
1065
|
304
|
254
|
677
|
647
|
84
|
80
|
Female Diabetics |
|
|
|
|
|
|
|
35-40 |
85
|
15
|
12
|
50
|
49
|
20
|
20
|
41-50 |
207
|
101
|
97
|
98
|
96
|
8
|
7
|
51-65 |
451
|
156
|
126
|
258
|
238
|
37
|
28
|
Female
Non-Diabetics |
768
|
212
|
180
|
476
|
418
|
86
|
85
|
|
5000
|
2308
|
2117
|
2278
|
2151
|
414
|
384
|
Table XIII
Blood Sugar Levels Before & After Treatmet
Age
Group
|
No. Of
Patients
|
Fasting
110-115
|
Normal
|
Fasting
116-150
|
Normal
|
P.P
161-250
|
Normal
|
P.P
251-400
|
Normal
|
Male
Diabetics |
|
|
|
|
|
|
|
|
|
35-40 |
612
|
398
|
394
|
214
|
208
|
405
|
399
|
207
|
203
|
41-50 |
823
|
564
|
554
|
259
|
247
|
530
|
518
|
293
|
283
|
51-65 |
989
|
598
|
538
|
391
|
364
|
611
|
553
|
378
|
349
|
Female
Diabetics |
|
|
|
|
|
|
|
|
|
35-40 |
85
|
48
|
45
|
37
|
35
|
42
|
40
|
43
|
40
|
41-50 |
207
|
140
|
136
|
67
|
65
|
131
|
126
|
76
|
75
|
51-65 |
451
|
299
|
259
|
152
|
145
|
305
|
275
|
146
|
129
|
|
3167
|
2047
|
1926
|
1120
|
1064
|
2024
|
1911
|
1143
|
1079
|
Table XIV
Drug Therapy
Verapamil
|
Beta-Blockers
|
ISDN
|
Digoxin & Diurects
|
40-80 mgm in 2 divided doses (mild cases) |
40-60 mgm in 2 divided doses in mild cases to
non-diabetics |
10 mgm 3 to 4 times per day |
0.25 mgm of digoxin & dytide 1 tab./day |
&
|
&
|
|
|
80-120 mgm in 3 divided doses (moderate cases) to
diabetics |
80-120 mgm in 3 divided doses in moderate cases to
non-diabetics |
|
|
ResultsMost of the patients started responding from second week
after the therapy was instituted. The improvement was noticed in the form of disappearance of
angina pectoris and feeling of well being. The ECG changes also started improving and from 3
months to one year all patients, except 348, had normal tracing even after treadmill (Table
VIII).
None of the patients suffered fresh myocardial infarction during the
study. The lipid profile also started improving after three months of institution of therapy
(Table IX).
Out of 5000 patients, 4652 patients had their normal levels of serum
cholesterol ranging from 160 Mgm to 240 Mgm%, serum triglycerides from 50-90 Mgm% (Table
X).
Total lipids from 500 Mgm to 800 Mgm% (Table XI), HDL
cholesterol ranging from 50 Mgm to 75 Mgm% (Table XII).
Out of 3167 diabetic patients, the blood sugar values, fasting and
post parendial, started coming down to normal levels (Table XIII) except in 177
patients, and all the oral hypoglycemic agents had to be withdrawn by the end of two months of
therapy. On the contrary, beta blockers, calcium channel blockers, isosorbide dinitrate and
diuretics, etc., which the patients were taking for hypertension and angina control, could not
be withdrawn completely (Table XIV) but their doses substantially reduced to half of the
quantity which they were taking. Similarly the hypertensive patients did not show any
significant change in their blood pressure levels. Total number of patients who did not respond
to treatment were 525 (348 ischaemic and 177 diabetics out of 5000 patients).
DiscussionIn the present study it has been noticed that the
plant had a definite role in the prevention and management of atherosclerotic heart disease.
The plant also had a definite role in controlling the blood sugar level in diabetic patients.
The exact mechanism of the plant Aloe vera and Husk of Isabgol is not known but it appears that
both these substances act by their high fibre contents and these substances need further
evaluation. In the entire study no untoward side effect was noticed and all the patients were
followed for a period of five years from July 1978 to June 1983 and all the patients turned up
for regular follow up and till date all the 5000 patients are surviving. The diabetic patients,
except 177 patients, are on diet control alone and none of them has ever complained about any
hypoglycemic episode during the study. There is no such study available in medical literature
where such a large number (5000 patients) of patients are being followed up for five years and
no Indian plant has ever been tried with such success. So this is a unique study of its own
type.
To conclude, the Indian plant Aloe vera, when mixed with the Husk of
Isabgol, was given to the patients of atherosclerotic heart disease, there was a definite and
substantial improvement (about 95%) in their clinical profile apart from biochemical changes
and ECG tracings. These two substances need further evaluation to find out the exact mechanism
of action on atherosclerosis.
AcknowledgementsAppreciation to my wife, Smt. Dr. Poonam Agarwal, for her excellent
co-operation in carrying out the present study.
|
Whole Leaf Aloe Vera - Prevention Of Atheromatous Heart Disease
|